ARS Pharmaceuticals, Inc. SPRY Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by ARS Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s common stock?
- ARS Pharmaceuticals, Inc. (SPRY) reported common stock of $10K in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s common stock changed year-over-year?
- ARS Pharmaceuticals, Inc.'s common stock decreased by 0.0% year-over-year, from $10K to $10K.
- What is the long-term trend for ARS Pharmaceuticals, Inc.'s common stock?
- Over 5 years (2020 to 2025), ARS Pharmaceuticals, Inc.'s common stock has grown at a 27.2% compound annual growth rate (CAGR), from $3K to $10K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).